Articles producció científica> Ciències Mèdiques Bàsiques

Gut microbiota-derived succinate: Friend or foe in human metabolic diseases?

  • Datos identificativos

    Identificador: imarina:6070100
    Handle: http://hdl.handle.net/20.500.11797/imarina6070100
  • Autores:

    Fernández-Veledo S
    Vendrell J
  • Otros:

    Autor según el artículo: Fernández-Veledo S; Vendrell J
    Departamento: Ciències Mèdiques Bàsiques
    Autor/es de la URV: Fernandez Veledo, Sonia / Vendrell Ortega, Juan José
    Palabras clave: Succinate Microbiota Metabolism microbiota metabolism
    Resumen: © 2019, The Author(s). There is now a wealth of evidence showing that communication between microbiota and the host is critical to sustain the vital functions of the healthy host, and disruptions of this homeostatic coexistence are known to be associated with a range of diseases including obesity and type 2 diabetes. Microbiota-derived metabolites act both as nutrients and as messenger molecules and can signal to distant organs in the body to shape host pathophysiology. In this review, we provide a new perspective on succinate as a gut microbiota-derived metabolite with a key role governing intestinal homeostasis and energy metabolism. Thus, succinate is not merely a major intermediary of the TCA traditionally considered as an extracellular danger signal in the host, but also a by-product of some bacteria and a primary cross-feeding metabolite between gut resident microbes. In addition to maintain a healthy microbiome, specific functions of microbiota-derived succinate in peripheral tissues regulating host nutrient metabolism should not be rule out. Indeed, recent research point to some probiotic interventions directed to modulate succinate levels in the intestinal lumen, as a new microbiota-based therapies to treat obesity and related co-morbidities. While further research is essential, a large body of evidence point to succinate as a new strategic mediator in the microbiota-host cross-talk, which might provide the basis for new therapeutically approaches in a near future.
    Áreas temáticas: Medicina iii Endocrinology, diabetes and metabolism Endocrinology & metabolism Endocrinology
    Acceso a la licencia de uso: https://creativecommons.org/licenses/by/3.0/es/
    ISSN: 13899155
    Direcció de correo del autor: sonia.fernandez@urv.cat juanjose.vendrell@urv.cat
    Identificador del autor: 0000-0003-2906-3788 0000-0002-6994-6115
    Fecha de alta del registro: 2023-06-09
    Versión del articulo depositado: info:eu-repo/semantics/publishedVersion
    Enlace a la fuente original: https://link.springer.com/article/10.1007/s11154-019-09513-z
    URL Documento de licencia: http://repositori.urv.cat/ca/proteccio-de-dades/
    Referencia al articulo segun fuente origial: Reviews In Endocrine & Metabolic Disorders. 20 (4): 439-447
    Referencia de l'ítem segons les normes APA: Fernández-Veledo S; Vendrell J (2019). Gut microbiota-derived succinate: Friend or foe in human metabolic diseases?. Reviews In Endocrine & Metabolic Disorders, 20(4), 439-447. DOI: 10.1007/s11154-019-09513-z
    DOI del artículo: 10.1007/s11154-019-09513-z
    Entidad: Universitat Rovira i Virgili
    Año de publicación de la revista: 2019
    Tipo de publicación: Journal Publications
  • Palabras clave:

    Endocrinology,Endocrinology & Metabolism,Endocrinology, Diabetes and Metabolism
    Succinate
    Microbiota
    Metabolism
    microbiota
    metabolism
    Medicina iii
    Endocrinology, diabetes and metabolism
    Endocrinology & metabolism
    Endocrinology
  • Documentos:

  • Cerca a google

    Search to google scholar